Healthcare provider profile · identity verified

David Allen Young, MD

Internal Medicine · VANCOUVER, WA · NPI 1659485613

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	481	139
Losartan Potassium	Losartan Potassium	362	103
Lisinopril	Lisinopril	301	98
Amlodipine Besylate	Amlodipine Besylate	272	83
Simvastatin	Simvastatin	223	62
Trazodone Hcl	Trazodone Hcl	209	57
Levothyroxine Sodium	Levothyroxine Sodium	201	59
Atenolol	Atenolol	191	52
Potassium Chloride	Potassium Chloride	179	56
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	163	30
Metoprolol Tartrate	Metoprolol Tartrate	150	45
Pantoprazole Sodium	Pantoprazole Sodium	143	48
Hydrochlorothiazide	Hydrochlorothiazide	139	50
Tamsulosin Hcl	Tamsulosin Hcl	139	44
Gabapentin	Gabapentin	120	39
Albuterol Sulfate Hfa	Albuterol Sulfate	117	51
Metoprolol Succinate	Metoprolol Succinate	117	38
Furosemide	Furosemide	115	38
Rosuvastatin Calcium	Rosuvastatin Calcium	110	36
Pradaxa	Dabigatran Etexilate Mesylate	100	37
Duloxetine Hcl	Duloxetine Hcl	97	29
Metformin Hcl	Metformin Hcl	97	30
Tizanidine Hcl	Tizanidine Hcl	96	14
Fluoxetine Hcl	Fluoxetine Hcl	87	28
Metformin Hcl Er	Metformin Hcl	87	29
Oxycodone Hcl	Oxycodone Hcl	81	15
Sertraline Hcl	Sertraline Hcl	78	22
Buspirone Hcl	Buspirone Hcl	75	18
Warfarin Sodium	Warfarin Sodium	74	22
Omeprazole	Omeprazole	73	21
Ozempic	Semaglutide	72	12
Allopurinol	Allopurinol	71	20
Glipizide	Glipizide	71	23
Pravastatin Sodium	Pravastatin Sodium	66	21
Famotidine	Famotidine	59	19
Mirtazapine	Mirtazapine	59	19
Escitalopram Oxalate	Escitalopram Oxalate	57	19
Finasteride	Finasteride	52	19
Bisoprolol Fumarate	Bisoprolol Fumarate	51	16
Clopidogrel	Clopidogrel Bisulfate	51	16
Spironolactone	Spironolactone	50	15
Alendronate Sodium	Alendronate Sodium	49	18
Triamcinolone Acetonide	Triamcinolone Acetonide	49	30
Humulin N	Insulin Nph Human Isophane	48	14
Terazosin Hcl	Terazosin Hcl	48	15
Pregabalin	Pregabalin	47	18
Doxycycline Monohydrate	Doxycycline Monohydrate	44	33
Memantine Hcl	Memantine Hcl	43	suppressed
Fluticasone Propionate	Fluticasone Propionate	40	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	40	11
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	40	13
Eliquis	Apixaban	39	suppressed
Donepezil Hcl	Donepezil Hcl	38	13
Montelukast Sodium	Montelukast Sodium	38	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	suppressed
Topiramate	Topiramate	37	13
Jardiance	Empagliflozin	36	13
Morphine Sulfate Er	Morphine Sulfate	36	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	36	15
Acyclovir	Acyclovir	34	12
Humulin R	Insulin Regular, Human	34	suppressed
Ondansetron Odt	Ondansetron	32	13
Tramadol Hcl	Tramadol Hcl	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Carvedilol	Carvedilol	30	14
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Oxycontin	Oxycodone Hcl	29	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	29	suppressed
Estradiol	Estradiol	28	17
Alprazolam	Alprazolam	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Meloxicam	Meloxicam	26	suppressed
Nystatin	Nystatin	26	suppressed
Cefuroxime	Cefuroxime Axetil	25	22
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	suppressed
Alvesco	Ciclesonide	24	13
Ketoconazole	Ketoconazole	24	11
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Morphine Sulfate	Morphine Sulfate	22	suppressed
Nitroglycerin	Nitroglycerin	22	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	15	13
Amoxicillin	Amoxicillin	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	14	14
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Prednisone	Prednisone	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	11	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Digoxin	Digoxin	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	11	suppressed
Lactulose	Lactulose	11	suppressed
Liraglutide	Liraglutide	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error